Talbros Automotive Components Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 10:21 pm

Competitors of Talbros Automotive Components Ltd

All Competitor Stocks of Talbros Automotive Components Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:40 am

Below is a detailed analysis of the quarterly data for Talbros Automotive Components Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 207.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Mar 2025) to 207.00 Cr., marking an increase of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 171.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to 15.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00%.
• For Net Profit, as of Jun 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 22.00 Cr., marking a decrease of 5.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.60. The value appears to be declining and may need further review. It has decreased from 4.31 (Mar 2025) to 3.60, marking a decrease of 0.71.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:54 pm

Growth

Last Updated: September 5, 2025, 1:41 pm

Balance Sheet

Last Updated: June 16, 2025, 11:15 am

Below is a detailed analysis of the balance sheet data for Talbros Automotive Components Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 620.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2024) to 620.00 Cr., marking an increase of 95.00 Cr..
• For Borrowings, as of Mar 2025, the value is 94.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 99.00 Cr. (Mar 2024) to 94.00 Cr., marking a decrease of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 224.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 221.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 951.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 857.00 Cr. (Mar 2024) to 951.00 Cr., marking an increase of 94.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 221.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 16.00 Cr..
• For Investments, as of Mar 2025, the value is 209.00 Cr.. The value appears strong and on an upward trend. It has increased from 186.00 Cr. (Mar 2024) to 209.00 Cr., marking an increase of 23.00 Cr..
• For Other Assets, as of Mar 2025, the value is 498.00 Cr.. The value appears strong and on an upward trend. It has increased from 451.00 Cr. (Mar 2024) to 498.00 Cr., marking an increase of 47.00 Cr..
• For Total Assets, as of Mar 2025, the value is 951.00 Cr.. The value appears strong and on an upward trend. It has increased from 857.00 Cr. (Mar 2024) to 951.00 Cr., marking an increase of 94.00 Cr..

Notably, the Reserves (620.00 Cr.) exceed the Borrowings (94.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Talbros Automotive Components Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has decreased from 17.82 (Mar 24) to 15.30, marking a decrease of 2.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has decreased from 17.82 (Mar 24) to 15.30, marking a decrease of 2.52.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.59. This value is within the healthy range. It has decreased from 19.39 (Mar 24) to 17.59, marking a decrease of 1.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 102.49. It has increased from 87.02 (Mar 24) to 102.49, marking an increase of 15.47.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 102.49. It has increased from 87.02 (Mar 24) to 102.49, marking an increase of 15.47.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 133.98. It has increased from 126.08 (Mar 24) to 133.98, marking an increase of 7.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 23.86. This value is within the healthy range. It has increased from 20.61 (Mar 24) to 23.86, marking an increase of 3.25.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.69. This value is within the healthy range. It has increased from 16.42 (Mar 24) to 18.69, marking an increase of 2.27.
• For PBT / Share (Rs.), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 21.15 (Mar 24) to 16.47, marking a decrease of 4.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.42. This value is within the healthy range. It has decreased from 15.20 (Mar 24) to 12.42, marking a decrease of 2.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has decreased from 17.82 (Mar 24) to 15.30, marking a decrease of 2.52.
• For PBDIT Margin (%), as of Mar 25, the value is 17.80. This value is within the healthy range. It has increased from 16.35 (Mar 24) to 17.80, marking an increase of 1.45.
• For PBIT Margin (%), as of Mar 25, the value is 13.95. This value is within the healthy range. It has increased from 13.02 (Mar 24) to 13.95, marking an increase of 0.93.
• For PBT Margin (%), as of Mar 25, the value is 12.29. This value is within the healthy range. It has decreased from 16.77 (Mar 24) to 12.29, marking a decrease of 4.48.
• For Net Profit Margin (%), as of Mar 25, the value is 9.27. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 9.27, marking a decrease of 2.78.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has decreased from 14.13 (Mar 24) to 11.41, marking a decrease of 2.72.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.92. This value is below the healthy minimum of 15. It has decreased from 20.47 (Mar 24) to 14.92, marking a decrease of 5.55.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.91. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 16.91, marking a decrease of 0.34.
• For Return On Assets (%), as of Mar 25, the value is 9.93. This value is within the healthy range. It has decreased from 12.83 (Mar 24) to 9.93, marking a decrease of 2.90.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has decreased from 0.16 (Mar 24) to 0.13, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.03 (Mar 24) to 0.91, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.72, marking an increase of 0.34.
• For Quick Ratio (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has increased from 0.90 (Mar 24) to 1.25, marking an increase of 0.35.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.41. This value is below the healthy minimum of 4. It has increased from 3.17 (Mar 24) to 3.41, marking an increase of 0.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.36 (Mar 24) to 0.00, marking a decrease of 3.36.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.72 (Mar 24) to 0.00, marking a decrease of 2.72.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.64 (Mar 24) to 0.00, marking a decrease of 96.64.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.28 (Mar 24) to 0.00, marking a decrease of 97.28.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 10.75. This value is within the healthy range. It has increased from 9.59 (Mar 24) to 10.75, marking an increase of 1.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.87 (Mar 24) to 6.60, marking an increase of 1.73.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,480.83. It has decreased from 1,701.36 (Mar 24) to 1,480.83, marking a decrease of 220.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.79. This value is within the healthy range. It has decreased from 2.19 (Mar 24) to 1.79, marking a decrease of 0.40.
• For EV / EBITDA (X), as of Mar 25, the value is 10.06. This value is within the healthy range. It has decreased from 13.37 (Mar 24) to 10.06, marking a decrease of 3.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 2.08 (Mar 24) to 1.77, marking a decrease of 0.31.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.63 (Mar 24) to 0.00, marking a decrease of 96.63.
• For Price / BV (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has decreased from 3.02 (Mar 24) to 2.31, marking a decrease of 0.71.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 2.08 (Mar 24) to 1.77, marking a decrease of 0.31.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness